Becker's Healthcare December 19, 2023
Paige Twenter

Chronic drug shortages are difficult to resolve because of multiple races to drive down prices on generics, The New York Times reported Dec. 19.

When a medication falls into shortage — which can happen because of high demand, quality control issues, its main supplier closing up shop or other reasons — there’s little incentive for other drugmakers to pick up the pace. More than a dozen current and former executives in the generic drug industry told the Times there are many risks with suddenly increasing production.

Prices of the most common critical drugs are very cheap. For instance, cancer drug mainstays carboplatin and cisplatin, which have been in shortage for months, cost about $15 per dose.

More...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech, Supply Chain, Technology
PBM reform dropped in Congress' funding package
2025 and Beyond: Key Trends to Watch in Pharmacy
Mark Cuban: A Master Disrupter for American Healthcare
Despite Trump’s Tough Talk On PBMs, GOP House Lets Them Off The Hook
What's next for Amazon in healthcare?

Share This Article